Abstract
Keywords:
cardiovascular diseases; hypoxia; inflammation; mitogen-activated protein kinase; monocrotaline; pulmonary hypertension.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis / drug effects
-
Cell Proliferation
-
Cells, Cultured
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Hypertension, Pulmonary* / metabolism
-
Hypertension, Pulmonary* / physiopathology
-
Hypertension, Pulmonary* / therapy
-
Hypoxia / metabolism
-
Inflammation / metabolism
-
Intracellular Signaling Peptides and Proteins* / antagonists & inhibitors
-
Intracellular Signaling Peptides and Proteins* / metabolism
-
Muscle, Smooth, Vascular / metabolism*
-
Oxidative Stress / drug effects
-
Peptides / pharmacology*
-
Protein Serine-Threonine Kinases* / antagonists & inhibitors
-
Protein Serine-Threonine Kinases* / metabolism
-
Pulmonary Artery* / metabolism
-
Pulmonary Artery* / physiopathology
-
Rats
-
Rats, Sprague-Dawley
-
Vascular Remodeling / drug effects
Substances
-
Enzyme Inhibitors
-
Intracellular Signaling Peptides and Proteins
-
MMI-0100
-
Peptides
-
MAP-kinase-activated kinase 2
-
Protein Serine-Threonine Kinases